Twist Bioscience
TWST
Revenue for Twist Bioscience (TWST)
Revenue in 2023 (TTM): $0.26 B
According to Twist Bioscience
's latest financial reports the company's current revenue (TTM
) is $0.27 B.
In 2022 the company made a revenue of $0.21 B an increase over the years 2021 revenue that were of $0.14 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Twist Bioscience from 2018 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.26 B | 21.58% |
| 2022 | $0.21 B | 47.61% |
| 2021 | $0.14 B | 44.6% |
| 2020 | $0.10 B | 68.33% |
| 2019 | $60.05 M | 84.19% |
| 2018 | $32.6 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $0.24 M | -99.91% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $21.83 M | -92.13% | 🇬🇧 UK |
 Novavax NVAX | $0.69 B | 149.91% | 🇺🇸 USA |
 Novocure
NVCR | $0.52 B | 89.44% | Jersey |